We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$12.9B
AUM Growth
+$779M
Cap. Flow
+$371M
Cap. Flow %
2.87%
Top 10 Hldgs %
15.93%
Holding
1,520
New
111
Increased
436
Reduced
503
Closed
64

Top Buys

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$36.1M
2
ORCL icon
Oracle
ORCL
+$31.6M
3
MA icon
Mastercard
MA
+$29.1M
4
MRK icon
Merck
MRK
+$26.3M
5
CTRA
Coterra Energy
CTRA
+$21.4M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Healthcare 15.33%
3 Financials 12.61%
4 Consumer Discretionary 10.12%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSY
1426
DELISTED
Insys Therapeutics, Inc.
INSY
$16K ﹤0.01%
+52,606
New +$142K
SRCL
1427
DELISTED
Stericycle Inc
SRCL
$15K ﹤0.01%
316
LILA icon
1428
Liberty Latin America Class A
LILA
$1.64B
$14K ﹤0.01%
1,279
SGMO
1429
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$14K ﹤0.01%
1,300
FCEL icon
1430
FuelCell Energy
FCEL
$1.73B
$13K ﹤0.01%
2,511
+1,726
+220% +$92.8K
HOUS
1431
DELISTED
Anywhere Real Estate
HOUS
$13K ﹤0.01%
1,783
PXLW icon
1432
Pixelworks
PXLW
$38.2M
$13K ﹤0.01%
+373
New +$16K
NEWR
1433
DELISTED
New Relic, Inc.
NEWR
$13K ﹤0.01%
150
AQB icon
1434
AquaBounty Technologies
AQB
$4.66M
$11K ﹤0.01%
175
FTR
1435
DELISTED
Frontier Communications Corp.
FTR
$11K ﹤0.01%
6,443
-252,812
-98% -$515K
NBIX icon
1436
Neurocrine Biosciences
NBIX
$16.8B
$10K ﹤0.01%
110
BRS
1437
DELISTED
Bristow Group, Inc.
BRS
$10K ﹤0.01%
+108,133
New +$79.8K
NTLA icon
1438
Intellia Therapeutics
NTLA
$1.49B
$9K ﹤0.01%
520
THO icon
1439
Thor Industries
THO
$3.9B
$9K ﹤0.01%
160
IBA
1440
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$9K ﹤0.01%
200
ADAP
1441
DELISTED
Adaptimmune Therapeutics
ADAP
$8K ﹤0.01%
1,900
FOLD
1442
DELISTED
Amicus Therapeutics
FOLD
$8K ﹤0.01%
620
SLCA
1443
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$8K ﹤0.01%
661
CLDR
1444
DELISTED
Cloudera, Inc.
CLDR
$8K ﹤0.01%
1,500
SRCI
1445
DELISTED
SRC Energy Inc
SRCI
$8K ﹤0.01%
1,578
HRTX icon
1446
Heron Therapeutics
HRTX
$93.9M
$7K ﹤0.01%
400
CPL
1447
DELISTED
CPFL Energia S.A.
CPL
$7K ﹤0.01%
420
RDUS
1448
DELISTED
Radius Health, Inc.
RDUS
$6K ﹤0.01%
235
IOVA icon
1449
Iovance Biotherapeutics
IOVA
$1.82B
$5K ﹤0.01%
+220
New +$3.31K
SIG icon
1450
Signet Jewelers
SIG
$3.61B
$5K ﹤0.01%
274
-5,627
-95% -$121K

Similar funds

KBC Group's Q2 2019 Portfolio in Review

As of Q2 2019, KBC Group held 1,520 positions worth $12.9B, up 6.4% from $12.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

KBC Group's Q2 2019 filing shows 111 new, 436 increased, 503 reduced and 64 closed positions. Its largest new stake was Dow Inc: 262,436 shares worth $12.9M. The largest sale was Citrix Systems Inc, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q2 2019 buy was Dow Inc: 262,436 shares worth $12.9M.
  • KBC Group added most to eBay in Q2 2019, an estimated $36.1M increase.
  • KBC Group's biggest Q2 2019 reduction was Citrix Systems Inc, cutting an estimated $34M.
  • KBC Group fully exited Twenty-First Century Fox, Inc. Class A in Q2 2019, selling an estimated $26.7M.
  • KBC Group's ten largest holdings make up 16% of its $12.9B portfolio in Q2 2019.
  • KBC Group opened 111 new positions and closed 64 in Q2 2019.
  • KBC Group's portfolio value rose 6.4% quarter-over-quarter to $12.9B.

Based on KBC Group's 13F filing for Q2 2019, filed 30 Jul 2019.